Literature DB >> 12432219

Evolutionary clues to the molecular function of fanconi anemia genes.

Eric Blom1, Henri J van de Vrugt, Johan P de Winter, Fré Arwert, Hans Joenje.   

Abstract

Fanconi anemia (FA) is an autosomal recessively inherited disease with diverse clinical symptoms including developmental anomalies, predisposition to neoplasia, and a deficiency of hematopoietic stem cells resulting in progressive aplastic anemia. FA is genetically heterogeneous with at least 8 genes being implicated on the basis of functional complementation studies. To date, six FA genes are known: FANCA, FANCC, FANCD2, FANCE, FANCF and FANCG, all of which encode orphan proteins sharing no homology to each other nor to any other known protein. In addition, they do not appear to possess any domains with homology to currently known protein domains, which makes a prediction about their molecular action difficult. Studying the molecular evolution of FA genes and their products using sensitive database search methods such as PSI-BLAST may provide novel insight into the nature of the FA pathway and its relationship to hematopoiesis, embryonic development and the origin of malignancies. Preliminary results of such an approach show that at least one FA protein, FANCG, may contain a known domain, suggesting that this protein is a member of the family of tetratricopeptide repeat-containing proteins. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12432219     DOI: 10.1159/000065659

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  5 in total

1.  Hypomorphic mutations in the gene encoding a key Fanconi anemia protein, FANCD2, sustain a significant group of FA-D2 patients with severe phenotype.

Authors:  Reinhard Kalb; Kornelia Neveling; Holger Hoehn; Hildegard Schneider; Yvonne Linka; Sat Dev Batish; Curtis Hunt; Marianne Berwick; Elsa Callen; Jordi Surralles; Jose A Casado; Juan Bueren; Angeles Dasi; Jean Soulier; Eliane Gluckman; C Michel Zwaan; Rosalina van Spaendonk; Gerard Pals; Johan P de Winter; Hans Joenje; Markus Grompe; Arleen D Auerbach; Helmut Hanenberg; Detlev Schindler
Journal:  Am J Hum Genet       Date:  2007-04-06       Impact factor: 11.025

2.  Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol.

Authors:  Qing-Shuo Zhang; Laura Marquez-Loza; Laura Eaton; Andrew W Duncan; Devorah C Goldman; Praveen Anur; Kevin Watanabe-Smith; R Keaney Rathbun; William H Fleming; Grover C Bagby; Markus Grompe
Journal:  Blood       Date:  2010-09-08       Impact factor: 22.113

3.  A protein prioritization approach tailored for the FA/BRCA pathway.

Authors:  Anneke Haitjema; Bernd W Brandt; Najim Ameziane; Patrick May; Jaap Heringa; Johan P de Winter; Hans Joenje; Josephine C Dorsman
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

4.  Comprehensive analysis of macrophage-related multigene signature in the tumor microenvironment of head and neck squamous cancer.

Authors:  Bo Lin; Hao Li; Tianwen Zhang; Xin Ye; Hongyu Yang; Yuehong Shen
Journal:  Aging (Albany NY)       Date:  2021-02-11       Impact factor: 5.682

Review 5.  Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models.

Authors:  Sietske T Bakker; Johan P de Winter; Hein te Riele
Journal:  Dis Model Mech       Date:  2013-01       Impact factor: 5.758

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.